Ingar Holme

Institutt for Eksperimentell Medisinsk Forskning

4

h-index

4

Publications

1,050

Citations

Publications

4 shown

Cholesterol reduction and its impact on coronary artery disease and total mortality

Ingar Holme

1995 The American Journal of Cardiology 60 citations

Comparison of Efficacy and Safety of Atorvastatin (80 mg) to Simvastatin (20 to 40 mg) in Patients Aged <65 Versus ≥65 Years With Coronary Heart Disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] Study)

Matti J. Tikkanen , Ingar Holme , Nilo B. Cater +7 more

2009 The American Journal of Cardiology 55 citations

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

Hallvard Holdaas , Bengt Fellström , Alan G. Jardine +13 more

2003 The Lancet 918 citations

Effect of greater LDL-C reductions on prognosis-the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial

Terje R. Pedersen , Ole Færgeman , Ingar Holme +2 more

1999 Atherosclerosis 17 citations

Frequent Co-Authors

Hallvard Holdaas

Bengt Fellström

Uppsala University Hospital

Alan G. Jardine

University of Glasgow

Gudrun Nyberg

Sahlgrenska University Hospital

Per Fauchald

Carola Grönhagen‐Riska

Helsinki University Hospital

Researcher Info

h-index: 4
Publications: 4
Citations: 1,050
Institution: Institutt for Eksperimentell Medisinsk Forskning

External Links

Google Scholar

Impact Metrics

h-index 4

h-index: Number of publications with at least h citations each.